GENEVA, SWITZERLAND / ACCESS Newswire / December 23, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX ) (MindMaze Therapeutics or the Company), a commercial-stage company delivering evidence-based, precision digital treatments for neurological diseases, today outlined the evolution of its global reimbursement strategy to enable scalable patient access and sustainable commercial growth for next-generation neurotherapeutics. Building on […]

Seattle, Washington–(Newsfile Corp. – December 23, 2025) – KaJ Labs has announced a strategic expansion of its blockchain innovation roadmap through a multi-sector investment strategy aimed at supporting sustainable growth across the decentralized technology landscape. The initiative reflects KaJ Labs’ continued focus on advancing blockchain and artificial intelligence through structured research, ecosystem development, and long-term

(NASDAQ:REGN),(Paris:SAN),(NASDAQ:SNY), Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupixent is the first and only biologic medicine to demonstrate improved lung function in this young patient group in a randomized Phase 3 trial, and

(NasdaqGM:VEON), Almaty, Dubai and Tokyo, December 23, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON”), and Rakuten Group, Inc. (TSE: 4755), announced today that Beeline Kazakhstan Holding, VEON's digital operator in Kazakhstan, and Rakuten Symphony, a subsidiary of Rakuten Group, have signed a Memorandum of Understanding (MoU) to explore strategic collaboration on next-generation

(Paris:SAN), Sanofi and Regeneron's Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function compared to placebo (by 4.68% to 5.32%) Dupixent is the first and only biologic medicine

VEON's Beeline Kazakhstan and Rakuten Symphony Collaborate to Advance Next-Generation Connectivity and Digital Infrastructure GlobeNewswire December 23, 2025 Almaty, Dubai and Tokyo, December 23, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON”), and Rakuten Group, Inc. (TSE: 4755), announced today that Beeline Kazakhstan Holding, VEON's digital operator in Kazakhstan, and Rakuten Symphony, a

Press Release: Sanofi and Regeneron's Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma GlobeNewswire December 23, 2025 Sanofi and Regeneron's Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by

Dupixent(R) (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma GlobeNewswire December 23, 2025 Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupixent is the first and only biologic

Copenhagen , Dec. 23, 2025 (GLOBE NEWSWIRE) — ISS has partnered with the NSW Government since 1994. Under the new contract, ISS will continue to deliver cleaning services to schools, Technical and Further Education (TAFE) colleges, and various government facilities across three regions in New South Wales. The contract duration is 2.5 years and begins

ISS renews major contract with Australia's New South Wales Government Department of Education ISS, a leading global workplace experience and facilities services company, has extended its long-standing partnership with the New South Wales (NSW) Government Department of Education in Australia. The renewed contract has an annual value of approximately DKK 800 million. GlobeNewswire December 23,